These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 4679557)

  • 101. [Oxypertine, peperazine derivative of tryptophan with neuroleptic and dynamogenic properties].
    Breulet M; Labar P; Delree C; Collard J; Bobon J
    Acta Neurol Psychiatr Belg; 1968 Feb; 68(2):116-27. PubMed ID: 4972600
    [No Abstract]   [Full Text] [Related]  

  • 102. [Water intoxication and syndrome of urinary tract obstruction relief during prolonged neuroleptic treatment].
    Glomaud D; Chodkiewicz JP; Mérienne L; Salamagne JC
    Anesth Analg (Paris); 1976; 33(5):833-44. PubMed ID: 827219
    [No Abstract]   [Full Text] [Related]  

  • 103. Scopolamine sleep treatment in private practise.
    Goldner RD
    Int J Neuropsychiatry; 1967 Jun; 3(3):234-47. PubMed ID: 6039771
    [No Abstract]   [Full Text] [Related]  

  • 104. Drug therapy of thought disorder in chronic paranoid schizophrenia: a longitudinal study.
    Wilson IC; Paulson GW; Sandifer MG
    Dis Nerv Syst; 1968 Aug; 29(8):550-1. PubMed ID: 4877898
    [No Abstract]   [Full Text] [Related]  

  • 105. [Leading symptom of anxiety and tension and its concomitant somatic manifestations. A multicenter trial of fluspirilene versus bromazepam].
    Thilmann J
    Fortschr Med; 1983 Oct; 101(37):1676-8. PubMed ID: 6139327
    [TBL] [Abstract][Full Text] [Related]  

  • 106. [Study of a new psychotropic agent: sulpiride (1403 RD). I. Method and clinical results].
    Borenstein P; Cujo P; Champion C; Olivenstein C
    Ann Med Psychol (Paris); 1968 Jun; 2(1):90-9. PubMed ID: 5670026
    [No Abstract]   [Full Text] [Related]  

  • 107. [Clinical experience with a new neuroleptic (R. 6238)].
    Bonhour A; Borel RO
    Prensa Med Argent; 1971 Aug; 58(24):1265-6. PubMed ID: 4940120
    [No Abstract]   [Full Text] [Related]  

  • 108. [Fluspirilene in schizophrenia maintenance therapy and its interaction with dexetimide].
    Skopová J; Faltus F; Filip V; Jirák R; Karen P; Posmurová M; Dobiásová A
    Cesk Psychiatr; 1985 Dec; 81(6):414-9. PubMed ID: 3912068
    [No Abstract]   [Full Text] [Related]  

  • 109. Differences in clinical effects of three phenothiazines in "acute" schizophrenia.
    Dis Nerv Syst; 1967 Jun; 28(6):369-83. PubMed ID: 5342391
    [No Abstract]   [Full Text] [Related]  

  • 110. [Clinical experiences with the neuroleptic butyryl-perazine (Wu 2791-AWD). Contribution to the syndromatic concept of endogenous psychoses].
    Kühne GE; Rennert H
    Z Arztl Fortbild (Jena); 1965 Feb; 59(3):140-6. PubMed ID: 5885796
    [No Abstract]   [Full Text] [Related]  

  • 111. Psychopharmacology and psychopathology.
    Cole JO
    Proc Annu Meet Am Psychopathol Assoc; 1969; 58():253-65. PubMed ID: 4898738
    [No Abstract]   [Full Text] [Related]  

  • 112. Utilization and safety of fluspirilene in nonpsychotic outpatients.
    Schmidt LG
    Pharmacopsychiatry; 1989 Sep; 22(5):188-91. PubMed ID: 2813507
    [TBL] [Abstract][Full Text] [Related]  

  • 113. [Clinical evaluation of the TPN 12 (Sandoz) preparation in the treatment of mental disorders].
    Bukowczyk A; Korta B; Michalska M; Spisla B; Trzeciakowa O; Bryś J
    Psychiatr Pol; 1971; 5(5):571-5. PubMed ID: 4400423
    [No Abstract]   [Full Text] [Related]  

  • 114. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
    Huygens H; Vereecken JL; Tanghe A
    Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374
    [No Abstract]   [Full Text] [Related]  

  • 115. Prediction of neuroleptic effects from animal data.
    Vinar O; Krsiak M
    Adv Biochem Psychopharmacol; 1974; 9(0):675-83. PubMed ID: 4836228
    [No Abstract]   [Full Text] [Related]  

  • 116. [Chemical therapy technics in psychiatry: neuroleptic therapy of paranoic psychoses].
    Volmat R; Allers G; Vittouris N
    Therapie; 1971; 26(6):1167-73. PubMed ID: 4401718
    [No Abstract]   [Full Text] [Related]  

  • 117. [Long term treatment of schizophrenia with penfluridol].
    Haring C
    Med Welt; 1977 Apr; 28(13):639-42. PubMed ID: 404499
    [No Abstract]   [Full Text] [Related]  

  • 118. [Comparative clinical-psychiatric experiences with thiaxanthene-derivatives with special consideration of flupenthixol].
    Poeldinger W
    Arzneimittelforschung; 1967 Sep; 17(9):1133-5. PubMed ID: 5632287
    [No Abstract]   [Full Text] [Related]  

  • 119. Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.
    Denijs EL; Vereecken JL
    Psychiatr Neurol Neurochir; 1973; 76(1):47-59. PubMed ID: 4699105
    [No Abstract]   [Full Text] [Related]  

  • 120. [Use of new drug treatments in child psychiatry (long-acting neuroleptics, antidepressive agents and lithium)].
    Dugas M; Velin J; Guériot C; Frohwirth C
    Cah Med; 1973 Sep; 14(9):711-6. PubMed ID: 4779496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.